Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Keratosis, Actinic 2Pituitary Neoplasms 1Pain 1Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Lung Neoplasms 1Hemorrhage 1Haloperidol 1Growth Hormone-Secreting Pituitary Adenoma 1Brain Neoplasms 1Anemia 1Acromegaly 1

Interventions

radium Ra 223 dichloride 1niraparib 1enzalutamide 1darolutamide 1capivasertib 1cabazitaxel 1apalutamide 1abiraterone 1Solutions 1Prednisone 1Injections 1Docetaxel 1Carboplatin 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Metastatic Castration-resistant Prostate Cancer (mCRPC) × Solutions × Clear all
NCT03903835 2025-04-09

ProBio

Karolinska Institutet

Phase 3 Recruiting
750 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡